Intensive blood pressure control and cognitive impairment in chronic kidney disease: The jury is still out

Eur J Intern Med. 2022 Jul:101:32-33. doi: 10.1016/j.ejim.2022.05.023. Epub 2022 May 29.

Authors

Giorgio Gentile¹, Kathryn Mckinney², Gianpaolo Reboldi³

Affiliations

¹ College of Medicine and Health. University of Exeter, Exeter, United Kingdom; Department of Nephrology, Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom. Electronic address: g.gentile2@exeter.ac.uk.
² Faculty of Biology, College of Letters and Science, University of Wisconsin-Madison, Madison, United States.
³ Department of Medicine and Centro di Ricerca Clinica e Traslazionale (CERICLET), University of Perugia, Perugia, Italy.

PMID: 35649739
DOI: 10.1016/j.ejim.2022.05.023

No abstract available

Publication types

Comment

MeSH terms

Antihypertensive Agents / therapeutic use
Blood Pressure
Cognitive Dysfunction* / etiology
Humans
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / drug therapy

Substances

Antihypertensive Agents